Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Saphnelo approved in EU for SLE
Investegate announcements from AstraZeneca PLC, Saphnelo approved in EU for SLE
Source: investegate.co.uk
Severe Systemic Lupus News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Severe Systemic Lupus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Severe Systemic Lupus Today - Breaking & Trending Today
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite receiving standard therapy. Saphnelo is the first biologic for SLE approved in ...
Source: pharmiweb.com
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosusSaphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosusAstraZeneca’s Saphnelo (anifrolumab) has been approved in the...
Source: pharmiweb.com